Lobbyist

HARDER, DANIEL

COVERED POSITION(S)
  • STAFF ASSISTANT/CLERK - HOUSE WAYS AND MEANS 2014
  • LEGISLATIVE DIRECTOR - REP. MIKE BISHOP 2015-2018

FILINGS KEY

Client Is Connected to China as Indicated in Filing
Client Is Connected to China as per Heritage Foundation Analysis
No Known Client Connection to China
Lobbying Terminated
Based on data as of March 9, 2026
Associated Filings (8)

Client
OURARING INC

Lobby Firm
MAYER BROWN LLP

Filing Year
2025

Lobbying Terminated
False

Foreign Entities Connected to Client

Entity Name
Country
Ownership %
OURA HEALTH LTD.
Finland
100.0

Lobbyists

View Filing

Client
GALAXY DIGITAL HOLDINGS LP

Lobby Firm
MAYER BROWN LLP

Filing Year
2025

Lobbying Terminated
False

Foreign Entities Connected to Client

None

Lobbyists

View Filing

Client
MICHELIN NORTH AMERICA INC

Lobby Firm
MAYER BROWN LLP

Filing Year
2025

Lobbying Terminated
False

Foreign Entities Connected to Client

Entity Name
Country
Ownership %
COMPAGNIE GENERALE DES ETABLISSEMENTS MICHELIN SCA
France
100.0

Lobbyists

View Filing

Client
ITO EN NORTH AMERICA INC

Lobby Firm
MAYER BROWN LLP

Filing Year
2025

Lobbying Terminated
False

Foreign Entities Connected to Client

Entity Name
Country
Ownership %
ITO EN LTD
Japan
100.0

Lobbyists

View Filing

Client
PRIMEMAX MEDICAL INDUSTRIES INC

Lobby Firm
MAYER BROWN LLP

Filing Year
2025

Lobbying Terminated
False

Foreign Entities Connected to Client

Entity Name
Country
Ownership %
INTCO MEDICAL TECHNOLOGY CO., LTD.
China
100.0

Lobbyists

View Filing

Client
SYENSQO USA LLC

Lobby Firm
MAYER BROWN LLP

Filing Year
2025

Lobbying Terminated
False

Foreign Entities Connected to Client

Entity Name
Country
Ownership %
SYENSQO SA
Belgium
100.0

Lobbyists

View Filing

Client
SOLONIAN RESOURCES LLC

Lobby Firm
MAYER BROWN LLP

Filing Year
2025

Lobbying Terminated
False

Foreign Entities Connected to Client

None

Lobbyists

View Filing

Client
NOVOCURE

Lobby Firm
MAYER BROWN LLP

Filing Year
2025

Lobbying Terminated
False

Foreign Entities Connected to Client

Entity Name
Country
Ownership %
NOVOCURE
Switzerland
100.0

Lobbyists

View Filing